Omaha, NENCT06774131Now EnrollingIRB Ready

Upper Tract Urothelial Cancer Clinical Trial in Omaha, NE

Access cutting-edge upper tract urothelial cancer treatment through this clinical trial at a research site in Omaha. Study-provided care at no cost to qualified participants.

Sponsored by UroGen Pharma Ltd.

Quick Self-Assessment

See if you qualify for this Omaha location

Preparing your pre-screening questions...

Expert Care in Omaha

Access upper tract urothelial cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related upper tract urothelial cancer treatment provided free

Apply for This Omaha Location

Check if you qualify for this upper tract urothelial cancer clinical trial in Omaha, NE

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Omaha

    Convenient for NE residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Omaha site if eligible
  4. 4Begin participation

About This Upper Tract Urothelial Cancer Study in Omaha

This study will evaluate the efficacy and safety of UGN-104, a new formulation of UGN-101 (approved in the United States and Israel as JELMYTO \[mitomycin\] for pyelocalyceal solution), instilled in the upper urinary tract (UUT) of patients with low-grade upper tract urothelial cancer (LG-UTUC).

Sponsor: UroGen Pharma Ltd.

Who Can Participate

Inclusion Criteria

Provide written informed consent, which includes compliance with the requirements and restrictions listed in the informed consent form and protocol. 2. Naive or recurrent patients with LG, non-invasive UTUC in the pyelocalyceal system, with the following disease characteristics: 1. At least 1 measurable papillary LG tumor, evaluated visually, ≤ 15 mm. The largest lesion should not exceed 15 mm. Debulking to ≤ 15 mm is permitted. 2. Biopsy taken from at least 1 tumor located above the ureteropelvic junction revealing LG urothelial carcinoma (UC). Patients who have been biopsied within 8 weeks before Screening for this study and shown to have LG UC may have these historical biopsies used for enrollment into the study and do not require repeat biopsy during Screening. 3. Patient should have at least 1 remaining papillary LG tumor evaluated visually with a diameter of at least 5 mm post-biopsy. 4. Wash urine cytology sampled from the pyelocalyceal syste

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Omaha?

Yes, this clinical trial (NCT06774131) has an active research site in Omaha, NE that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Upper Tract Urothelial Cancer Treatment Options in Omaha, NE

If you're searching for upper tract urothelial cancer treatment options in Omaha, NE, this clinical trial (NCT06774131) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Omaha research site is actively enrolling participants for this clinical trial. You'll receive care from experienced upper tract urothelial cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all upper tract urothelial cancer clinical trials near you to find additional studies recruiting in your area.

More Bladder Cancer Trials in Omaha, NE

See all bladder cancer clinical trials recruiting in Omaha — not just this study.

Browse Bladder Cancer Trials in Omaha →

Browse More Trials by Condition

Bladder Cancer TrialsPulmonary Embolism TrialsRheumatoid Arthritis TrialsAll Conditions →

Ready to Join in Omaha?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Omaha, NE